DK3377511T3 - Azithromycinderivater med epithelial barriere-forbedrende egenskaber - Google Patents

Azithromycinderivater med epithelial barriere-forbedrende egenskaber Download PDF

Info

Publication number
DK3377511T3
DK3377511T3 DK16804720.7T DK16804720T DK3377511T3 DK 3377511 T3 DK3377511 T3 DK 3377511T3 DK 16804720 T DK16804720 T DK 16804720T DK 3377511 T3 DK3377511 T3 DK 3377511T3
Authority
DK
Denmark
Prior art keywords
epithelial barrier
enhancing properties
azithromycin derivatives
azithromycin
derivatives
Prior art date
Application number
DK16804720.7T
Other languages
English (en)
Inventor
Fredrik Lehmann
Fridrik Runar Gardarsson
Peter Teodorovic
Original Assignee
Epiendo Pharmaceuticals Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55133040&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3377511(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Epiendo Pharmaceuticals Ehf filed Critical Epiendo Pharmaceuticals Ehf
Application granted granted Critical
Publication of DK3377511T3 publication Critical patent/DK3377511T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK16804720.7T 2015-11-19 2016-11-21 Azithromycinderivater med epithelial barriere-forbedrende egenskaber DK3377511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1520419.1A GB201520419D0 (en) 2015-11-19 2015-11-19 Compounds
PCT/EP2016/078360 WO2017085329A1 (en) 2015-11-19 2016-11-21 Azithromycin derivatives with epithelial barrier enhancement properties

Publications (1)

Publication Number Publication Date
DK3377511T3 true DK3377511T3 (da) 2020-08-17

Family

ID=55133040

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16804720.7T DK3377511T3 (da) 2015-11-19 2016-11-21 Azithromycinderivater med epithelial barriere-forbedrende egenskaber

Country Status (19)

Country Link
US (3) US10723752B2 (da)
EP (2) EP3708573A1 (da)
JP (2) JP6849896B2 (da)
KR (1) KR20180077282A (da)
CN (2) CN114933620A (da)
CA (1) CA3005088A1 (da)
CY (1) CY1123418T1 (da)
DK (1) DK3377511T3 (da)
ES (1) ES2810703T3 (da)
GB (1) GB201520419D0 (da)
HK (1) HK1255270A1 (da)
HR (1) HRP20201246T1 (da)
HU (1) HUE050307T2 (da)
LT (1) LT3377511T (da)
PL (1) PL3377511T3 (da)
PT (1) PT3377511T (da)
RS (1) RS60698B1 (da)
SI (1) SI3377511T1 (da)
WO (1) WO2017085329A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520419D0 (en) * 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds
WO2023038852A1 (en) * 2021-09-07 2023-03-16 Zoetis Services Llc Immunomodulating azalides
GB202404587D0 (en) 2024-03-28 2024-05-15 Epiendo Pharmaceuticals Ehf Chemical forms

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
HRP20010018A2 (en) * 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
US20050171342A1 (en) * 2002-02-15 2005-08-04 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CN100577681C (zh) 2002-07-08 2010-01-06 葛兰素伊斯特拉齐瓦基森塔萨格勒布公司 用于治疗炎性疾病和病症的新化合物、组合物和方法
ITMI20022292A1 (it) 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
EP1841776B1 (en) * 2005-01-13 2008-12-31 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Decladinosyl-macrolides with anti-inflammatory activity
AU2006215315B2 (en) * 2005-01-13 2012-02-16 Glaxo Group Limited Macrolides with anti-inflammatory activity
CN1837225A (zh) * 2005-08-23 2006-09-27 济南思创生物技术有限公司 阿奇霉素衍生物及其制法和药物应用
WO2007129646A1 (ja) 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. マクロライド誘導体
CN101074251B (zh) * 2007-06-22 2011-06-15 山东大学 阿奇霉素4"-氨甲酸酯衍生物、制备方法及其药物组合物
WO2009006403A2 (en) * 2007-06-29 2009-01-08 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
WO2010086351A1 (en) * 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity
AU2011313862A1 (en) 2010-10-10 2013-05-30 Synovo Gmbh Anti-inflammatory macrolides
GB201105633D0 (en) * 2011-04-01 2011-05-18 Norbrook Lab Ltd Antibotic compounds
WO2013148874A1 (en) * 2012-03-27 2013-10-03 Burnet Michael W Anti-inflammatory macrolides
AU2014252462A1 (en) * 2013-04-10 2015-10-01 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
GB201520419D0 (en) 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds

Also Published As

Publication number Publication date
PT3377511T (pt) 2020-08-21
ES2810703T3 (es) 2021-03-09
HK1255270A1 (zh) 2019-08-09
CY1123418T1 (el) 2021-12-31
WO2017085329A1 (en) 2017-05-26
CN108290919B (zh) 2022-06-17
HRP20201246T1 (hr) 2020-11-13
CN114933620A (zh) 2022-08-23
US10723752B2 (en) 2020-07-28
JP2021073303A (ja) 2021-05-13
US11236120B2 (en) 2022-02-01
LT3377511T (lt) 2020-09-25
CN108290919A (zh) 2018-07-17
JP6849896B2 (ja) 2021-03-31
KR20180077282A (ko) 2018-07-06
JP2018534324A (ja) 2018-11-22
EP3708573A1 (en) 2020-09-16
CA3005088A1 (en) 2017-05-26
JP7256558B2 (ja) 2023-04-12
EP3377511A1 (en) 2018-09-26
US20200317710A1 (en) 2020-10-08
RS60698B1 (sr) 2020-09-30
US20180354981A1 (en) 2018-12-13
SI3377511T1 (sl) 2020-10-30
GB201520419D0 (en) 2016-01-06
EP3377511B1 (en) 2020-05-13
US20220106349A1 (en) 2022-04-07
PL3377511T3 (pl) 2020-11-16
HUE050307T2 (hu) 2020-11-30

Similar Documents

Publication Publication Date Title
DK3319956T3 (da) Substituerede oxopyridinderivater
BR112017019371A2 (pt) derivados tetracíclicos ativos em termos pesticidas com substituintes contendo enxofre
BR112017019372A2 (pt) derivados tetracíclicos ativos em termos pesticidas com substituintes contendo enxofre
BR112018000052A2 (pt) derivados policíclicos ativos em termos pesticidas com substituintes contendo enxofre
DK3390738T3 (da) More-sky-vindue
DOS2016000090S (es) Cierre
DE112016000772A5 (de) Profilhalterung
DK3372589T3 (da) Pyrimidinderivat
HK1255270A1 (zh) 具有上皮屏障增强特性的阿奇黴素衍生物
DK3193936T3 (da) Antimikrobielle midler med forøget virkning
DK3380465T3 (da) Diaminopyridinderivativer
DK3356589T3 (da) Smelteblæste webs med forbedrede egenskaber
DE112016003063A5 (de) Verstellvorrichtung
DK3286193T3 (da) Indolderivater
FR3035464B1 (fr) Pendule- butee laterale -bimatiere
DE112017003625A5 (de) Difluorstilben-Derivate
IT201600077076A1 (it) Bicchiere
DK3303316T3 (da) Ethynylderivater
UA32689S (uk) Віконний косяк - утеплювач
SM201600001S1 (it) Ferma cerniera
UY4471S (es) Perfil
UY4470S (es) Perfil
UA30913S (uk) Міжкімнатні двері
FI11001U1 (fi) Ovi
UA30904S (uk) Міжкімнатні двері